Jeremy Bordeaux, MD
- Dermatologic Surgery
- High risk basal cell and squamous cell carcinomas
- Mohs Micrographic Surgery
- Reconstructive Surgery of Skin Cancer Wounds
- Surgical Management of Skin Cancers
Patient Satisfaction Reviews
4.8 out of 5
Patient Comments (3)
Reviewed On 8/18/2018
Excellent experience, nothing negative
Reviewed On 6/11/2018
Dr. Bordeaux's office runs like well oiled machine -- good communication between the teams and the flow of patients moves efficiently due to the organization and expertise of all involved in care. I have had many procedures done by Dr. Bordeaux and I appreciate his carefulness and concern about scarring -- he's fabulous!
Reviewed On 5/29/2018
It was nice that all members of the team introduced themselves before starting to "work" on me.
- Dermatology - American Board of Dermatology
Fellowship | MOHS-Micrographic Surgery
MOHS-Micrographic Surgery - University Of Massachusetts Memorial Medical Center - University Campus (2006 - 2007)
Residency | Dermatology
Dermatology - University Of Massachusetts Memorial Medical Center - University Campus (2003 - 2006)
Internship | Internal Medicine
Internal Medicine - The Jewish Hospital - Mercy Health (2002 - 2003)
University Of North Carolina At Chapel Hill (2000 - 2002)
Duke University School Of Medicine (1998 - 2002)
North Carolina State University (1994 - 1998)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jeremy Bordeaux did not disclose any Outside Relationships with Industry.